Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice (original) (raw)
References
Adams JM and Cory S . (1998). Science, 281, 1322–1326.
Beck MT, Peirce SK and Chen WY . (2002). Oncogene, 21, 5047–5055.
Ben-Jonathan N, Liby K, McFarland M and Zinger M . (2002). Trends Endocrinol. Metab., 13, 245–250.
Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Ghosh N, Chikhikar PR and Trivedi TI . (2000). Eur. J. Surg. Oncol., 26, 540–547.
Binart N, Ormandy CJ and Kelly PA . (2000). Adv. Exp. Med. Biol., 480, 85–92.
Binder C, Marx D, Binder L, Schour A and Hiddemann W . (1996). Ann. Oncol., 7, 129–133.
Blackwell RE and Hammond KR . (1999). Hormonal Control of Normal Breast Morphology and Function, Manni A (ed). Humana Press: New Jersey, pp. 3–20. Google Scholar
Brockman JL, Schroeder MD and Schuler LA . (2002). Mol. Endocrinol., 16, 774–784.
Chen NY, Holle L, Li W, Peirce SK, Beck MT and Chen WY . (2002). Int. J. Oncol., 20, 813–818.
Chen WY, Ramamoorthy P, Chen NY, Sticca RP and Wagner TE . (1999). Clin. Cancer Res., 5, 3583–3593.
Clevenger CV, Chang WP, Ngo W, Pashe TLM, Montone KT and Tomaszewski JE . (1995). Am. J. Pathol., 146, 695–705.
Clevenger CV, Furth PA, Hankinson SE and Schuler LA . (2003). Endocrine Rev., 24, 1–27.
Corbacho AM, Martinez De La Escalera G and Clapp C . (2002). J. Endocrinol., 175, 219–238.
Cory S and Adams JM . (2002). Nat. Rev., 2, 647–656.
Debatin KM, Poncet D and Kroemer G . (2002). Oncogene, 21, 8786–8803.
Ginsburg E and Vonderhaar BK . (1995). Cancer Res., 55, 2591–2595.
Green DR and Beere HM . (1999). Apoptosis and Cancer Chemotherapy: Mechanisms of Apoptosis, Hickman JA and Dive C (ed). Humana Press: New Jersey, pp. 157–174. Book Google Scholar
Korsmeyer SJ . (1999). Cancer Res., 59, 1693–1700.
Krajewski S, Krawjewska M, Turner BC, Pratt C, Howard B, Zapata JM, Frenkel V, Robertson S, Ionov Y, Yamamoto H, Perucho M, Takayama S and Reed JC . (1999). Endocr. Relat. Cancer, 6, 29–40.
Krumenacker JS, Buckley DJ, Leff MA, McCormack JT, de Jong G, Gout PW, Reed JC, Miyashita T, Magnuson NS and Buckley AR . (1998). Endocrine, 2, 163–170.
Kumar R, Vadlamundi RK and Adam L . (2000). Endocr. Relat. Cancer, 7, 257–269.
Kuo CB, Wu W, Xu X, Yang L, Chen C, Coss D, Birdsall B, Nasseri D and Walker AM . (2002). Cell Tissue Res., 309, 429–437.
Marti A, Feng Z, Altermatt HJ and Jaggi R . (1997). Eur. J. Cell. Biol., 73, 158–165.
Nagasawa H, Miur K, Niki K and Namiki H . (1985). Exp. Clin. Endocrinol., 86, 357–360.
Peirce SK and Chen WY . (2001). J. Endocrinol., 17, R1–R4.
Schorr K, Li M, Bar-Peled U, Lewis A, Heredia A, Lewis B, Knudson CM, Korsmeyer SJ, Jager R, Weiher H and Furth PA . (1999). Cancer Res., 59, 2541–2545.
Vonderhaar BK . (1999). Endocr. Relat. Cancer, 6, 389–404.
Vonderhaar BK . (1998). Pharmacol. Ther., 79, 169–178.
Wennbo H, Kindblom J, Isaksson OG and Tornell J . (1997). Endocrinology, 138, 4410–4415.
Zhang H, Xu S, Krajewski M, Krajewski Z, Xie S, Fuess S, Kitada S, Pawlowski A, Godzik A and Reed JC . (2000). Proc. Natl. Acad. Sci. USA, 97, 2597–2602.